Skip to content
TrialScanner

NCT03793010

Study to Evaluate the Efficacy and Safety of FX006 in Patients With Hip Osteoarthritis

Phase 3TerminatedPCRXLead

Registry record

Lead sponsor
Pacira Pharmaceuticals, Inc
Conditions
Osteoarthritis, Hip
Primary completion
Aug 7, 2019Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03793010 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.